Diffuse Large B-cell Lymphoma in The Elderly: Real-world Outcomes of Immunochemotherapy in Asian Population

We evaluated real-life treatment outcomes of elderly diffuse large B cell lymphoma (DLBCL) from an Asian population. Medical records of 192 patients over 60 years old treated with first-line immunochemotherapy were retrospectively analyzed. Elderly patients

Source: Clinical Lymphoma, Myeloma and Leukemia - June 7, 2016 Category: Hematology Authors: Ja Min Byun, Jeong-Ok Lee, Beodeul Kang, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Soo-Mee Bang, Jong Seok Lee Tags: Original Study Source Type: research